Search research articles
Contact Us
Filters
Showing results (1241-1250 of 1,377) with videos related to
Page
of 138
Sort By:
Journal of the American College of Cardiology
|
August 9, 2008
No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial)
Joseph A Blatt, Jeanne E Poole, George W Johnson, et al.
Journal of the American College of Cardiology
|
December 20, 2005
Cardiac resynchronization therapy: Part 1--issues before device implantation
Jeroen J Bax, Theodore Abraham, S Serge Barold, et al.
Kidney International Reports
|
July 18, 2025
Urinary Clusterin is a Biomarker of Renal Epithelial Senescence and Predicts Human Kidney Disease Progression
David P Baird, Maximilian Reck, Ross Campbell, et al.
American Heart Journal
|
May 3, 2005
Conducting economic evaluations alongside multinational clinical trials: toward a research consensus
Shelby D Reed, Kevin J Anstrom, Ameet Bakhai, et al.
Nature Communications
|
October 15, 2025
Low circulating miR-190a-5p predicts progression of chronic kidney disease
David P Baird, Jinnan Zang, Katie L Connor, et al.
European Journal of Heart Failure
|
May 24, 2024
Balcinrenone plus dapagliflozin in patients with heart failure and chronic kidney disease: Results from the phase 2b MIRACLE trial
Carolyn S P Lam, Lars Køber, Koichiro Kuwahara, et al.
The New England Journal of Medicine
|
September 16, 2024
Preoperative Chemoradiotherapy for Resectable Gastric Cancer
Trevor Leong, B Mark Smithers, Michael Michael, et al.
American Heart Journal
|
August 10, 2016
Health-related quality of life outcomes with prasugrel among medically managed non-ST-segment elevation acute coronary syndrome patients: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) trial
Padma Kaul, E Magnus Ohman, J David Knight, et al.
Diabetes Care
|
July 8, 2018
Validation of Plasma Biomarker Candidates for the Prediction of eGFR Decline in Patients With Type 2 Diabetes
Andreas Heinzel, Michael Kammer, Gert Mayer, et al.
American Heart Journal
|
May 22, 2025
Use of coronary artery bypass graft surgery and percutaneous coronary intervention and associated outcomes in the ISCHEMIA trial
Harvey D White, Sean M O'Brien, William E Boden, et al.
Page
of 138
Search research articles
Search
Showing results (1241-1250 of 1,377) with videos related to
Sort By:
Page
of 138
Journal of the American College of Cardiology
|
August 9, 2008
No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial)
Joseph A Blatt, Jeanne E Poole, George W Johnson, et al.
Journal of the American College of Cardiology
|
December 20, 2005
Cardiac resynchronization therapy: Part 1--issues before device implantation
Jeroen J Bax, Theodore Abraham, S Serge Barold, et al.
Kidney International Reports
|
July 18, 2025
Urinary Clusterin is a Biomarker of Renal Epithelial Senescence and Predicts Human Kidney Disease Progression
David P Baird, Maximilian Reck, Ross Campbell, et al.
American Heart Journal
|
May 3, 2005
Conducting economic evaluations alongside multinational clinical trials: toward a research consensus
Shelby D Reed, Kevin J Anstrom, Ameet Bakhai, et al.
Nature Communications
|
October 15, 2025
Low circulating miR-190a-5p predicts progression of chronic kidney disease
David P Baird, Jinnan Zang, Katie L Connor, et al.
European Journal of Heart Failure
|
May 24, 2024
Balcinrenone plus dapagliflozin in patients with heart failure and chronic kidney disease: Results from the phase 2b MIRACLE trial
Carolyn S P Lam, Lars Køber, Koichiro Kuwahara, et al.
The New England Journal of Medicine
|
September 16, 2024
Preoperative Chemoradiotherapy for Resectable Gastric Cancer
Trevor Leong, B Mark Smithers, Michael Michael, et al.
American Heart Journal
|
August 10, 2016
Health-related quality of life outcomes with prasugrel among medically managed non-ST-segment elevation acute coronary syndrome patients: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) trial
Padma Kaul, E Magnus Ohman, J David Knight, et al.
Diabetes Care
|
July 8, 2018
Validation of Plasma Biomarker Candidates for the Prediction of eGFR Decline in Patients With Type 2 Diabetes
Andreas Heinzel, Michael Kammer, Gert Mayer, et al.
American Heart Journal
|
May 22, 2025
Use of coronary artery bypass graft surgery and percutaneous coronary intervention and associated outcomes in the ISCHEMIA trial
Harvey D White, Sean M O'Brien, William E Boden, et al.
Page
of 138